Atlas Trials

Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response

Clinical trial NCT03154710 · TERMINATED

Trial details

NCT number
NCT03154710
Sponsor
Weprom
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Lymphoma, T-CellLymphoma, Large B-Cell, DiffuseLymphoma, Hodgkin
Start date
2017-07-12
Primary completion
2020-10-14
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.